Pages that link to "Q30482391"
Jump to navigation
Jump to search
The following pages link to Prediction of intestinal absorption: comparative assessment of GASTROPLUS and IDEA. (Q30482391):
Displaying 44 items.
- Utility of physiologically based absorption modeling in implementing Quality by Design in drug development (Q30498061) (← links)
- Case studies for practical food effect assessments across BCS/BDDCS class compounds using in silico, in vitro, and preclinical in vivo data (Q30576914) (← links)
- In silico predictions of drug solubility and permeability: two rate-limiting barriers to oral drug absorption (Q30847239) (← links)
- Prediction of in vivo drug interactions with eplerenone in man from in vitro metabolic inhibition data (Q30938859) (← links)
- Recent advances in pharmacokinetic extrapolation from preclinical data to humans (Q31049599) (← links)
- From physicochemistry to absorption and distribution: predictive mechanistic modelling and computational tools (Q33254667) (← links)
- Mechanistic approaches to predicting oral drug absorption (Q33432960) (← links)
- Prediction of modified release pharmacokinetics and pharmacodynamics from in vitro, immediate release, and intravenous data (Q33442896) (← links)
- ADME-Tox in drug discovery: integration of experimental and computational technologies (Q34228973) (← links)
- Intestinal absorption and bioavailability of traditional Chinese medicines: a review of recent experimental progress and implication for quality control (Q34340279) (← links)
- Utility of physiologically based pharmacokinetic models to drug development and rational drug discovery candidate selection. (Q35057285) (← links)
- ADMET in silico modelling: towards prediction paradise? (Q35075770) (← links)
- Pectin-based systems for colon-specific drug delivery via oral route (Q35134484) (← links)
- Application of drug delivery technologies in lead candidate selection and optimization (Q35829128) (← links)
- Prediction methods and databases within chemoinformatics: emphasis on drugs and drug candidates (Q36043183) (← links)
- Evaluation and suggested improvements of the Biopharmaceutics Classification System (BCS). (Q36885229) (← links)
- Prediction of human pharmacokinetics--gastrointestinal absorption (Q36885247) (← links)
- Predictive models for oral drug absorption: from in silico methods to integrated dynamical models (Q36909311) (← links)
- On the anticipation of the human dose in first-in-man trials from preclinical and prior clinical information in early drug development (Q36985094) (← links)
- Physiologically based approaches towards the prediction of pharmacokinetics: in vitro-in vivo extrapolation (Q37008900) (← links)
- Drug absorption modeling as a tool to define the strategy in clinical formulation development (Q37254283) (← links)
- Towards quantitative prediction of oral drug absorption (Q37265500) (← links)
- The in silico child: using simulation to guide pediatric drug development and manage pediatric pharmacotherapy. (Q37521422) (← links)
- Physiologically based pharmacokinetics (PBPK). (Q37550553) (← links)
- An update on computational oral absorption simulation (Q37937047) (← links)
- Impact of preformulation on drug development (Q38093663) (← links)
- Experimental models for predicting drug absorption and metabolism (Q38107970) (← links)
- In vitro-in vivo extrapolation (IVIVE) for predicting human intestinal absorption and first-pass elimination of drugs: principles and applications. (Q38131859) (← links)
- Pros and cons of methods used for the prediction of oral drug absorption. (Q38177366) (← links)
- Lipid-associated oral delivery: Mechanisms and analysis of oral absorption enhancement (Q38926514) (← links)
- Drug discovery and regulatory considerations for improving in silico and in vitro predictions that use Caco-2 as a surrogate for human intestinal permeability measurements (Q39205763) (← links)
- High glucose concentration in isotonic media alters caco-2 cell permeability (Q42564494) (← links)
- Physiological modeling and assessments of regional drug bioavailability of danoprevir to determine whether a controlled release formulation is feasible (Q42604420) (← links)
- Towards a platform PBPK model to characterize the plasma and tissue disposition of monoclonal antibodies in preclinical species and human (Q44019028) (← links)
- Influence of molecular properties on oral bioavailability of lipophilic drugs - mapping of bulkiness and different measures of polarity (Q45371827) (← links)
- Selection of the most suitable dissolution method for an extended release formulation based on IVIVC level A obtained on cynomolgus monkey (Q46058098) (← links)
- Physiologically based pharmacokinetic modelling to predict single- and multiple-dose human pharmacokinetics of bitopertin (Q46379587) (← links)
- Clinical Bioavailability of the Novel BACE1 Inhibitor Lanabecestat (AZD3293): Assessment of Tablet Formulations Versus an Oral Solution and the Impact of Gastric pH on Pharmacokinetics (Q47555674) (← links)
- In silico ADME-Tox modeling: progress and prospects (Q47658021) (← links)
- Predicting pharmacokinetic food effects using biorelevant solubility media and physiologically based modelling (Q51485283) (← links)
- Quantitative biopharmaceutics classification system: the central role of dose/solubility ratio (Q52005114) (← links)
- Oral absorption of poorly water-soluble drugs: computer simulation of fraction absorbed in humans from a miniscale dissolution test. (Q52668360) (← links)
- Using Human Plasma as an Assay Medium in Caco-2 Studies Improves Mass Balance for Lipophilic Compounds (Q58731266) (← links)
- Computational Absorption Prediction (Q59188905) (← links)